PRAGUE, Czech Republic, April 24, 2018 -- This week at the industry’s premier flow cytometry conference, CYTO 2018, Cytek Biosciences Inc. will be on the show floor highlighting its CytekTM Aurora flow cytometry system with enhanced features. This unique platform has been embraced by researchers around the world since making its debut at CYTO 2017, and the deployments so far have been validating the application flexibility of the Cytek Aurora. From extra-cellular vesicles to highly multiparametric applications beyond what were initially envisioned and more, the breadth of applications being performed on the Cytek Aurora continues to grow.
“At this time last year, we introduced the scientific community to an all-new full spectrum flow cytometer that enables new discoveries and deeper biological insights at an affordable cost,” noted Dr. Wenbin Jiang, CEO of Cytek Biosciences. “Now, Cytek Aurora has been sold into four continents and is at work all over the globe. CYTO 2018 is the perfect place for us to showcase how we have expanded Cytek Aurora’s features and application abilities over the past year and set the stage for future innovations to come.”
Cytek Aurora offers capabilities that go beyond flow cytometry systems that come with a much higher price tag. With a simplified workflow, greater flexibility, and a lower cost of ownership, the Cytek Aurora is the embodiment of Cytek’s mission to make high end, high quality flow cytometry accessible to a larger number of researchers.
Cytek Aurora will be demonstrated at CYTO 2018 in Prague, Czech Republic, from April 28 – May 2 at booth #33. CYTO attendees are also encouraged to learn more about the Cytek Aurora through the following CYTO events and displays:
-
- Wednesday, May 2 – Commercial Tutorial: ‘Expanding Application Capabilities Using Full Spectrum Cytometry’
- Poster: ‘Minimizing the Effects of Spectral Overlap by Unmixing Versus Compensation,’ Program Number: 294. Poster Board Number: B289.
Please visit www.cytekbio.com for more information.
About Cytek Biosciences
Cytek Biosciences Inc. is a leading flow cytometry solution provider that provides compact, affordable instruments with high multiplexing capability and a wide range of services to support researchers and clinicians. Cytek is headquartered in Fremont, California with branch offices and distribution channels across the globe. To learn more, visit www.cytekbio.com and follow them on LinkedIn.
Media Contact:
Justine Houston-Brown
Lages & Associates
(949) 453-8080
[email protected]
A photo accompanying this announcement is available at http://resource.globenewswire.com/Resource/Download/0c0b45d4-94bf-44ef-bcd8-8c3cf3b572ad


Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Instagram Outage Disrupts Thousands of U.S. Users
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



